efficacy evaluation of livergol in children with attention deficit hyperactivity disorder

Studying the effect of Livergol in children with attention deficit hyperactivity disorder

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20160813029327N22

Enrollment

Registered

2024-01-17

Start date

2024-01-21

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

attention deficit hyperactivity disorder. Attention-deficit hyperactivity disorders

Interventions

Intervention 1: Intervention group: patients will receive Ritalin and one tablet of livergol 70 mg daily for 60 days. Intervention 2: Control group: patients will receive Ritalin and one placebo table

Eligibility

Sex/Gender

All

Age

6 Years to 15 Years

Inclusion criteria

Inclusion criteria: age between 6-15 years old receiving written informed consent from patients diagnosis of ADHD is based on K_SADS by the Psychiatrist

Exclusion criteria

Exclusion criteria: children with other psychiatric disorders children with an allergy or previous side effects to Livergol Drug allergies History of seizures Pregnancy Lactation

Design outcomes

Primary

Measure	Time frame
The Conners ADHD rating scales. Timepoint: At the entry and day 60. Method of measurement: the Conners ADHD rating scales.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRamin Abrishami

Islamic Azad University

r_abrishami@iaups.ac.ir+98 21 2264 2151

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026